Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Lockheed Martin Corporation (LMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Lockheed Martin Corporation — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while Lockheed Martin Corporation trades at $525.88 (market cap $120.53B). The key difference: Lockheed Martin Corporation is far larger — about 14.2× Hinge Health Inc. Class A Common Stock's market cap, and Lockheed Martin Corporation pays a 2.76% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Lockheed Martin Corporation for 86 Days on average.
| HNGE | LMT | |
|---|---|---|
Market Cap | $8.47B | $120.53B |
Volume | 1,624,526 | 1,477,073 |
Sector | Health | Industrials |
52-Week High | $105.14 | $676.70 |
52-Week Low | $31.17 | $439.19 |
Typical Hold Time | 0 Days | 86 Days |
Enterprise Value | $8.09B | $137.27B |
Dividend Yield | — | 2.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Lockheed Martin (LMT) trades at $504.02, down 1.54% on the day, with a bearish technical signal despite strong analyst support. The company reported mixed quarterly earnings with two misses and one beat, while maintaining robust cash flow generation and a 23-year dividend growth streak. Recent news highlights strategic AI partnerships and F-35 program developments.
LMT offers attractive valuation metrics with a P/E of 18.58 and strong analyst consensus pointing to 24% upside to the $625.64 price target. However, execution risks on fixed-price contracts and recent earnings volatility warrant caution despite the company's dominant defense contracting position and stable government funding.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Lockheed Martin Corporation
Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →
